🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

RecruitingNAAges 12 Years - 80 YearsAllThe Second Hospital of Anhui Medical University
NCT07473648 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To compare the efficacy and tolerability of Electroconvulsive Therapy (ECT) and Magnetic Seizure Therapy (MST) in patients with major depressive disorder (MDD).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 12-80 years; * Diagnosis confirmed by two psychiatrists per DSM-5; * Stable medication regimen pre-enrollment; * Indicated for neuromodulation OR with visual field defects. Exclusion Criteria: * Major systemic diseases; * Prior neuromodulation within 3 months; * Pregnancy or potential pregnancy; * Metal implants or claustrophobia.
💊

What it tests

  • Electroconvulsive Therapy
  • Magnetic Seizure Therapy
📍

Where

1 site
Anhui Medical University
Hefei, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy